Trethera Revenue and Competitors
Estimated Revenue & Valuation
- Trethera's estimated annual revenue is currently $603k per year.
- Trethera's estimated revenue per employee is $100,500
Employee Data
- Trethera has 6 Employees.
- Trethera grew their employee count by 50% last year.
Trethera's People
Name | Title | Email/Phone |
---|---|---|
1 | Chairman and CEO | Reveal Email/Phone |
Trethera Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Trethera?
Based in Santa Monica, CA, Trethera is a privately-held company that aims to develop safer, more affordable and efficacious treatments for indications in oncology. The company is capitalizing on novel insights into the metabolic demands and vulnerabilities of cancer during rapid DNA replication and is developing small molecule compounds to precisely target these pathways. By targeting multiple pathways using rationally-designed combinations of drugs, Trethera’s therapeutic approaches are designed to improve efficacy and overcome the limitations of previous single agent therapies.
keywords:N/AN/A
Total Funding
6
Number of Employees
$603k
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 6 | -14% | N/A |
#2 | $0.4M | 6 | N/A | N/A |
#3 | $0.4M | 6 | -25% | N/A |
#4 | $0.4M | 6 | 0% | N/A |
#5 | $0.8M | 6 | -14% | N/A |